News
March Biosciences' G-Rex® Grant will be used to advance the manufacturing of their lead asset, MB-105, a novel investigational autologous CAR-T cell therapy targeting CD5 for patients with T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback